‹< Savella’s Pharmacology |
|US brand name: Savella|
| Generic name: milnacipran |
Fetzima (levomilnacipran ) is the long-acting version of Savella that is approved in the US for use as an antidepressant. Not that very many people wanted to use Savella as an antidepressant in the first place.
Name, Address, Serial Number (Generic and Overseas Availability)
Available in the US as a generic? No
Shapes & Sizes (How Supplied)
- 12.5 mg round blue tablets
- 25 mg round white tablets
- 50 mg oval white tablets
- 100 mg oval pink tablets
12.5 mg tabs have an F on one side and an L on the other. The rest have their dosage on one side and FL on the other.
Other Trade Names and Overseas Availability
Not including controlled/extended/sustained release suffixes (Efexor ER, Trevilor retard e.g.) or branded generics that are a hyphenate of the generic name and the drug company name (Apo-Citalopram e.g.).
- Ixel - France (where it was developed), Austria, Czech Republic, Estonia, Finland, Israel, Latvia, Luxembourg, Poland, Portugal, Slovakia
- Иксел (Iksel ) - Russia
- Dalcipran - Argentina, Czech Republic, Finland, France, Luxembourg, Poland, Portugal
- Milnace - India
- Tivanyl - Mexico
- トレドミン (Toledomin ) - Japan
- midalcipran - original generic name
- милнаципран - Russian transliteration of milnacipran
- milnacipranum - Latin INN
Full US PI sheet, Global SPCs & PILs, Other Consumer Review & Rating Sites, and Other Sites that may be of Interest
Savella’s Full US Prescribing Information / PI Sheet
Global PI Sheets
Consumer Review Sites
Other Sites of Interest
If you have any questions not answered here, please see the Crazymeds Savella discussion board.
- Savella Full US Prescribing Information
- Israeli Ixel SPC
- Stahl, Stephen M. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (Essential Psychopharmacology Series) Third edition Cambridge University Press 2008. ISBN:978–0521673761
- Stahl, Stephen M. The Prescriber’s Guide (Essential Psychopharmacology Series) Third edition Cambridge University Press 2009. ISBN:978–0521743990
- Ormseth, Michelle J., Anne E. Eyler, Cara L. Hammonds, and Chad S. Boomershine. “Milnacipran for the management of fibromyalgia syndrome.” Journal of Pain Research 3 (2010): 15. Published online 1 March, 2010
- Gendreau, R. Michael, Michael D. Thorn, Judy F. Gendreau, Jay D. Kranzler, Saulo Ribeiro, Richard H. Gracely, David A. Williams, Philip J. Mease, Samuel A. McLean, and Daniel J. Clauw. “Efficacy of milnacipran in patients with fibromyalgia.” The Journal of Rheumatology 32, no. 10 (2005): 1975-1985.
- Vitton, Olivier, Michael Gendreau, Judy Gendreau, Jay Kranzler, and Srinivas G. Rao. “A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.” Human Psychopharmacol Clinical Exp 19 (2004): S27-S35.
- Mease, Philip J., Daniel J. Clauw, R. Michael Gendreau, Srinivas G. Rao, Jay Kranzler, Wei Chen, and Robert H. Palmer. “The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial.” The Journal of Rheumatology 36, no. 2 (2009): 398-409.
- Arnold, Lesley M., R. Michael Gendreau, Robert H. Palmer, Judy F. Gendreau, and Yong Wang. “Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double‐blind, placebo‐controlled trial.” Arthritis & Rheumatism 62, no. 9 (2010): 2745-2756. Article first published online: 21 May 2010
- Vaishnavi, S. Neil, Charles B. Nemeroff, Susan J. Plott, Srinivas G. Rao, Jay Kranzler, and Michael J. Owens. “Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.” Biological Psychiatry 55, no. 3 (2004): 320-322.
- Li, Fanying, Christina Chin, Julie Wangsa, and John Ho. “Excretion and metabolism of milnacipran in humans after oral administration of milnacipran hydrochloride.” Drug Metabolism and Disposition 40, no. 9 (2012): 1723-1735.
‹< Savella’s Pharmacology |
Pages and Forum Topics Google Thinks are Relevant to Your Mental Health
||Keep Crazymeds on the air.
Donate some spare electronic currency
you have floating around The Cloud
|Last modified on Wed, 04 May, 2016 at 17:17:56 by JerodPoore||Page Author Jerod Poore||Date created Saturday, 04 October 2014 at 17:55:01|
|“Savella (milnacipran): Availability, Comments, Links, More” by Jerod Poore is copyright © 2014 Jerod Poore ||Published online 2014/10/05|
Savella, and all other drug names on this page and used throughout the site, are the trademarks of someone else. Savella’s PI Sheet will probably have the name of the manufacturer and trademark owner (they’re not always the same company) at or near the very bottom. Or ask Google who the owner is. The way pharmaceutical companies buy each other and swap products like Monopoly™ real estate, the ownership of the trademark may have changed without my noticing. It may of changed hands by the time you finished reading this article.
Page design and explanatory material by Jerod Poore, copyright © 2003 - 2016. All rights reserved. See the full copyright notice for full copyright details.
Don’t automatically believe everything you read on teh Intergoogles. No warranty is expressed or implied in this information. Consult one or more doctors and/or pharmacists before taking, or changing how you take any neurological and/or psychiatric medication. Your mileage may vary. What happened to us won’t necessarily happen to you. For more details see the Crazymeds big-ass disclaimer.
Enable Crazymeds’ Financial Solvency!
Enable Crazymeds to keep spreading our knowledge. Donate some spare e-currency you have floating around The Cloud.
Improve Your Social Media Skills
Sites That Probably Suck Less Than Crazymeds
Community, Info & Support